<code id='F0D883BFAE'></code><style id='F0D883BFAE'></style>
    • <acronym id='F0D883BFAE'></acronym>
      <center id='F0D883BFAE'><center id='F0D883BFAE'><tfoot id='F0D883BFAE'></tfoot></center><abbr id='F0D883BFAE'><dir id='F0D883BFAE'><tfoot id='F0D883BFAE'></tfoot><noframes id='F0D883BFAE'>

    • <optgroup id='F0D883BFAE'><strike id='F0D883BFAE'><sup id='F0D883BFAE'></sup></strike><code id='F0D883BFAE'></code></optgroup>
        1. <b id='F0D883BFAE'><label id='F0D883BFAE'><select id='F0D883BFAE'><dt id='F0D883BFAE'><span id='F0D883BFAE'></span></dt></select></label></b><u id='F0D883BFAE'></u>
          <i id='F0D883BFAE'><strike id='F0D883BFAE'><tt id='F0D883BFAE'><pre id='F0D883BFAE'></pre></tt></strike></i>

          hotspot

          hotspot

          author:knowledge    Page View:51
          Photo illustration based on photograph of The University of Texas MD Anderson Cancer Center in Houston, Texas in 2022
          Photo illustration: STAT; Photo: Adobe

          Three years ago, Jamie Lin, an early-career nephrologist at MD Anderson Cancer Center, made findings that could potentially help both save the kidneys of cancer patients and propel her career as a physician-scientist hoping to one day run her own lab. It was a promising start, but that’s when Lin says one of the Texas institute’s most powerful researchers interfered.

          Lin alleges in a lawsuit that prominent oncologist Padmanee Sharma derailed the publication of papers based on Lin’s work, threatened to undermine her fledgling career, and made defamatory comments about her in retaliation for resisting making Sharma an author on a paper and saying the senior researcher had made no substantial contribution to it.

          advertisement

          “Having this and another paper taken — what would’ve been important papers for my career,” Lin told STAT in an interview. “I’m sure that my career in research has just fallen off a cliff.”

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          focus

          Apple is now the first public company to be valued at $3 trillion
          Apple is now the first public company to be valued at $3 trillion

          6:09FILE-AnApplelogoadornsthefacadeofthedowntownBrooklynApplestoreonMarch14,2020,inNewYork.Applebeca

          read more
          Key Senate committee drafts bipartisan bill to stem drug shortages
          Key Senate committee drafts bipartisan bill to stem drug shortages

          AdobeWASHINGTON—TheSenateFinanceCommitteehasdraftedabipartisanbilltomitigatedrugshortagesbyrewarding

          read more
          Medicare details structure of new drug price negotiation program
          Medicare details structure of new drug price negotiation program

          MedicareonFridayreleasednewdetailsabouthowitsnewdrugpricenegotiationprogramwillwork,justtwomonthsbef

          read more

          Readout Newsletter: Biogen, Ionis, Johnson & Johnson news

          AdobeTheneed-to-knowthismorningBiogen and IonisPharmaceuticals are endingtheirdevelopment ofanexperi